参考文献/References:
[1] ZHAO Ying, QUAN Yue, LEI Ting, et al. The role of inflammasome NLPR3 in the development and therapy of periodontitis[J]. International Journal of Medical Sciences, 2022, 19(10): 1603-1614.
[2] SUN Xuefei, LI Zhidan, DONG Shaojie, et al. Long non-coding RNA SNHG5 promotes osteogenic differentiation of human periodontal ligament stem cells via mediating miR-23b-3p/Runx2 axis[J]. International Journal of Medical Sciences, 2023, 20(7): 958-968.
[3] HAN Ruiqi, ZHANG Wenjuan, ZHANG Lina, et al. Notoginsenoside R1 promotes proliferation and osteogenic differentiation of hPDLSCs via Wnt/β-catenin signaling pathway [J].Drug Design,Development and Therapy, 2022, 16: 4399-4409.
[4] WANG Hong, GAO Shuting, DISSANAYAKA W L. Circ_0003764 regulates the osteogenic differentiation of periodontal ligament stem cells[J].International Dental Journal, 2024, 74(5): 1110-1119.
[5] ZHOU Yuan, XU Zhuo, WANG Yuanyi, et al. LncRNA MALAT1 mediates osteogenic differentiation in osteoporosis by regulating the miR-485-5p/WNT7B axis[J]. Frontiers in Endocrinology (Lausanne), 2023,13: 922560.
[6] GU Nan,WANG Yao,LI Lingfeng, et al.The mechanism of lncRNA MALAT1 targeting the miR-124-3p/IGF2BP1 axis to regulate osteogenic differentiation of periodontal ligament stem cells[J]. Clinical Oral Investigations, 2024, 28(4): 219.
[7] 陈静涛, 王燕, 李宝东, 等.MiR-150-5p 下调通过激活Wnt 信号通路促进人牙周膜干细胞成骨分化及MMP2 表达[J]. 临床与病理杂志,2021,41(12):2763-2770. CHEN Jingtao, WANG Yan, LI Baodong, et al. MiR-150-5p downregulation facilitates osteogenic differentiation of human periodontal ligament stem cells and MMP2 expression via activating Wnt signaling pathway[J]. Journal of Clinical and Pathological Research, 2021, 41(12): 2763-2770.
[8] CUI Ziwei, QIN Ruoshan, FENG Jianbao, et al. XBP1s gene of endoplasmic reticulum stress enhances proliferation and osteogenesis of human periodontal ligament cells [J]. Tissue and Cell, 2023, 83: 102139.
[9] TELES F, COLLMAN R G, MOMINKHAN D,et al. Viruses, periodontitis, and comorbidities[J]. Periodontology 2000, 2022, 89(1): 190-206.
[10] HERRERA D,SANZ M,KEBSCHULL M, et al. Treatment of stage Ⅳ periodontitis: the EFP S3 level clinical practice guideline[J]. Journal of Clinical Periodontology, 2022, 49 (Suppl 22): 4-71.
[11] MOLINA A, SANZ-S?NCHEZ I, SANZ-MART?N I, et al. Complications in sinus lifting procedures:classification and management[J]. Periodontology 2000, 2022, 88(1): 103-115.
[12] MOHEBICHAMKHORAMI F, FATTAHI R, NIKNAM Z, et al. Periodontal ligament stem cells as a promising therapeutic target for neural damage[J]. Stem Cell Research & Therapy, 2022, 13(1): 273.
[13] ZHANG Yunfan, DOU Xueyu, ZHANG Lingyun, et al. Facile fabrication of a biocompatible composite gel with sustained release of aspirin for bone regeneration [J]. Bioactive Materials, 2021, 11: 130-139.
[14] TU Shaoqin, CHEN Yihua, FENG Yi, et al. LncRNA CYTOR facilitates osteogenic differentiation of human periodontal ligament stem cells by modulating SOX11 via sponging miR-6512-3p [J]. Stem Cells International,2023, 2023: 5671809.
[15] HUA Li, ZHANG Xiaohong. MALAT1 regulates osteogenic differentiation of human periodontal ligament stem cells through mediating miR-155-5p/ETS1 axis [J]. Tissue and Cell, 2021, 73: 101619.
[16] CHEN Pei, HUANG Yanhong, WANG Yarong, et al. MALAT1 overexpression promotes the proliferation of human periodontal ligament stem cells by upregulating fibroblast growth factor 2[J]. Experimental and Therapeutic Medicine, 2019, 18(3): 1627-1632.
[17] GU Yingzhi, BAI Yuxing. LncRNA MALAT1 promotes osteogenic differentiation through the miR-93-5p/SMAD5 axis[J]. Oral Diseases, 2024, 30(4): 2398-2409.
[18] YING Ming, ZHANG Bin. Daidzein promotes the proliferation and osteogenic differentiation of periodontal ligament stem cell[J]. Oral Diseases, 2023,29(3): 1226-1233.
[19] FAN Chun, LI Zhiyuan, JI Qiuxia, et al. Carboxymethyl chitin or chitosan for osteoinduction effect on the human periodontal ligament stem cells[J]. Dental Materials Journal, 2022, 41(3): 392-401.
[20] ZHANG Ying, WANG Fuyou, CHEN Guangxing,et al. LncRNA MALAT1 promotes osteoarthritis by modulating miR-150-5p/AKT3 axis [J]. Cell & Bioscience, 2019, 9: 54.
[21] HUANG Jing, XU Yuejing, HUANG Pengcheng. Salivary miR-150-5p as an indicator of periodontitis severity and regulator of human periodontal ligament fibroblast behavior by targeting AIFM2[J]. Journal of Periodontal Research, 2024, 59(1): 187-194.
[22] 廖烘, 刘伟, 龙运峰.LncRNA NEAT1 通过调节miR-125b-5p/IGFBP5 轴对血管瘤内皮细胞增殖、凋亡、迁移的实验研究[J]. 现代检验医学杂志,2023,38(3):65-71. LIAO Hong, LIU Wei, LONG Yunfeng. Experimental study on lncRNA NEAT1 on proliferation, apoptosis and migration of hemangioma endothelial cells by regulating miR-125b-5p/IGFBP5 axis[J]. Journal of Modern Laboratory Medicine, 2023, 38(3): 65-71.
[23] 陆佳艺, 伍倩琪, 陈伊燕, 等. 牙龈卟啉单胞菌来源的脂多糖通过X 盒结合蛋白1 调控脂肪细胞胰岛素信号通路的机制研究[J]. 华西口腔医学杂志,2022,40(2):148-154. LU Jiayi, WU Qianqi, CHEN Yiyan, et al. Mechanism of porphyromonas gingivalis-lipopolysaccharide in regulating the insulin signaling pathway in adipo-cytes via x-box binding protein 1[J]. West China Journal of Stomatology, 2022, 40(2): 148-154.
相似文献/References:
[1]张 振,李 芬.ceRNA与肿瘤[J].现代检验医学杂志,2016,31(04):128.[doi:10.3969/j.issn.1671-7414.2016.04.036]
[2]白盈盈,朱光旭,潘兴华.长链非编码RNA对结直肠癌潜在诊断价值的研究进展[J].现代检验医学杂志,2018,33(01):161.[doi:10.3969/j.issn.1671-7414.2018.01.001]
[3]洪 宏,袁建芬,喻海忠.乳腺癌患者血清长链非编码RNA ATB 表达水平检测及临床诊断价值[J].现代检验医学杂志,2020,35(02):22.[doi:10.3969 / j.issn.1671-7414.2020.02.007]
HONG Hong,YUAN Jian-fen,YU Hai-zhong.Detection and Clinical Diagnosis Value of Serum Long Non-codingRNA ATB in Patients with Breast Cancer[J].Journal of Modern Laboratory Medicine,2020,35(04):22.[doi:10.3969 / j.issn.1671-7414.2020.02.007]
[4]李 悦,徐焕铭,樊 华.基于TCGA 数据对60 岁以上不同分层急性髓系白血病患者相关lncRNA 的基因信息学分析[J].现代检验医学杂志,2020,35(03):20.[doi:10.3969/j.issn.1671-7414.2020.03.005]
LI Yue,XU Huan-ming,FAN Hua.Genetic Informatics Analysis of lncRNA Related to Patients with Different
Stratified Acute Myeloid Leukemia Over 60 Years Based on TCGA Database[J].Journal of Modern Laboratory Medicine,2020,35(04):20.[doi:10.3969/j.issn.1671-7414.2020.03.005]
[5]梁晓虎,郭俊霞,雷尚昆.食管癌组织中lnc RNA DNAJC3-AS1的表达及其与临床病理特征的相关性研究[J].现代检验医学杂志,2021,36(02):75.[doi:doi:10.3969/j.issn.1671-7414.2021.02.018]
LIANG Xiao-hu,GUO Jun-xia,LEI Shangkun.Expression of Lnc RNA DNAJC3-AS1 in Esophageal Carcinoma Tissues and Its Correlation with Clinicopathological Features[J].Journal of Modern Laboratory Medicine,2021,36(04):75.[doi:doi:10.3969/j.issn.1671-7414.2021.02.018]
[6]刘 霄,黄晓燕,王建华.长链非编码RNASNHG9在不同肿瘤中的最新研究进展[J].现代检验医学杂志,2021,36(04):176.[doi:10.3969/j.issn.1671-7414.2021.04.038]
LIU Xiao,HUANG Xiao-yan,WANG Jian-hua.Reasearch Progress of Long Non-coding RNA SNHG9 in Different Tumors[J].Journal of Modern Laboratory Medicine,2021,36(04):176.[doi:10.3969/j.issn.1671-7414.2021.04.038]
[7]朱 娇,孙国才,刘素荣,等.食管癌患者血清神经元特异性烯醇化酶与长链非编码RNA ITGA9-AS1水平联合检测的实验诊断价值研究[J].现代检验医学杂志,2021,36(05):62.[doi:10.3969/j.issn.1671-7414.2021.05.014]
ZHU Jiao,SUN Guo-cai,LIU Su-rong,et al.Experimental Diagnostic Value of Combined Detection of SerumNeuron-Specific Enolase and Long Non-Coding RNA ITGA9-AS1 inPatients with Esophageal Cancer[J].Journal of Modern Laboratory Medicine,2021,36(04):62.[doi:10.3969/j.issn.1671-7414.2021.05.014]
[8]刘立民,刘雪香,邹 燕,等.长链非编码RNA调控CD4+T淋巴细胞增殖分化和在免疫性疾病中的最新研究进展[J].现代检验医学杂志,2021,36(06):200.[doi:10.3969/j.issn.1671-7414.2021.06.044]
LIU Li-min,LIU Xue-xiang,ZOU Yan,et al.Roles of lncRNA in Regulating the Proliferation, Differentiation of CD4+T Lymphocytes and Immune Diseases[J].Journal of Modern Laboratory Medicine,2021,36(04):200.[doi:10.3969/j.issn.1671-7414.2021.06.044]
[9]张文娟,郭 逸,段 勇,等.健康献血者机采血小板储存中LncRNA LIPCAR 的表达及初步研究[J].现代检验医学杂志,2023,38(03):119.[doi:10.3969/j.issn.1671-7414.2023.03.021]
ZHANG Wen-juan,GUO Yi,DUAN Yong,et al.Expression and Preliminary Study of LncRNA LIPCAR in Platelet Storage of Mechanically Collected Platelets from Healthy Blood Donors[J].Journal of Modern Laboratory Medicine,2023,38(04):119.[doi:10.3969/j.issn.1671-7414.2023.03.021]
[10]李 轶,尚 立.非酒精性脂肪肝病患者血清LncRNA PVT1 表达水平与胰岛素抵抗及肝纤维化的相关性研究[J].现代检验医学杂志,2023,38(05):80.[doi:10.3969/j.issn.1671-7414.2023.05.015]
LI Yi,SHANG Li.Correlation of Serum LncRNA PVT1 Expression Level with Insulin Resistance and Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease[J].Journal of Modern Laboratory Medicine,2023,38(04):80.[doi:10.3969/j.issn.1671-7414.2023.05.015]